Displaying items by tag: Grand River Aseptic Manufacturing
GRAND RAPIDS — Johnson & Johnson hopes to bring a COVID-19 vaccine to market in the first half of 2021 in what would be a fraction of the time usually needed to develop and introduce a safe and effective new product.
GRAND RAPIDS — The $160 million federal contract to produce a COVID-19 vaccine when it’s ready elevates Grand River Aseptic Manufacturing Inc. into what Tom Ross calls the “big leagues.”
GRAND RAPIDS — A Grand Rapids pharmaceutical producer has landed a major $160 million federal contract to produce a new COVID-19 vaccine once it’s ready and available.
KALAMAZOO — A Grand Rapids mezzanine fund’s investment will enable Keystone Solutions Group to maintain its strong growth trajectory in the years ahead.